Rupas Biological Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 9.95%
- Ebitda
- Net Worth -4.87%
- Total Assets -33.62%
About Rupas Biological
Rupas Biological Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 May 2015 (Nine years and eight months 8 days old ). Its registered office is in South West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Singh, Varun Singh, Rovind Singh, and Two other members serve as directors at the Company.
Company Details
-
Location
South West Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900DL2015PTC280900
-
Company No.
280900
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 May 2015
-
Date of AGM
08 Jan 2024
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rupas Biological?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Singh
|
Director | 28-May-2015 | Current |
|
Umesh Singh
|
Director | 28-May-2015 | Current |
|
Sunny
|
Additional Director | 22-Dec-2015 | Current |
|
Rovind Singh
|
Director | 28-May-2015 | Current |
|
Prakash Singh
|
Director | 28-May-2015 | Current |
Financial Performance of Rupas Biological.
Rupas Biological Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 9.95% increase in profit. The company's net worth dipped by a decrease of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rupas Biological?
Unlock access to Rupas Biological's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rvl Scientific & Engineering Private LimitedUmesh Singh is a mutual person
-
Neovatus Health Solutions Private LimitedUmesh Singh is a mutual person
-
Anandmai Kosh Private Limited
Umesh Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rupas Biological?
Unlock and access historical data on people associated with Rupas Biological, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rupas Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rupas Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.